Latest news
First-in-Class RNA Degrader Targets Historically ‘Undruggable’ MYC in Preclinical Multiple Myeloma Models - Pharmacy TimesPharmacy Times · Mon, 10 Aug 2026 19:16:31 GMTFDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 16:43:18 GMTFDA Approves Oveporexton for Narcolepsy Type 1 - Pharmacy TimesPharmacy Times · Wed, 05 Aug 2026 22:07:12 GMT